Clinical Trial Update: 14-day PCAB-based High-dose Dual Therapy and14-day PCAB-based Triple Therapy vs 14-day PPI-based Reverse Hybrid Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing 14-day PCAB-based high-dose dual therapy and 14-day PCAB-based triple therapy against 14-day PPI-based reverse hybrid therapy f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Eradication
• Helicobacter Pylori Infection

Drugs mentioned

• PCAB-based high-dose dual therapy
• PCAB-based triple therapy
• PPI-based reverse hybrid therapy

Snippet

Sponsor: Kaohsiung Medical University | Conditions: Helicobacter Pylori Eradication | Phase 4 | Status: UNKNOWN